GleamWall
中文EN

ESYN EnerSyn Global Inc.

Wholesale-Drugs, Proprietaries & Druggists' Sundries · Nasdaq · SEC CIK 1897245 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-76.8%
TTM net income YoY-391.3%
TTM EPS YoY-244.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin50.7%
Operating margin—
Net margin-2,095.4%
FCF margin-327.6%
EBITDA margin—

Returns

ROE-69.0%
ROA-46.6%
ROIC (approx.)—
Asset turnover0.02x

Leverage & solvency

Liabilities / assets28.5%
Debt / equity0.00x
Current ratio3.29x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.16x
Accruals ratio-39.3%
Payout ratio—
Capex / revenue0.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$72,646$64,200$64,200$54,560$206,778$310,391$295,197$287,062
Cost of revenue$50,267$43,836$16,912$14,899$178,933$266,314$147,603$173,285
Gross profit$22,379$20,364$47,288$39,661$27,845$44,077$147,594$113,777
SG&A expense$3.10M$249,063$672,202$2.05M$229,239$383,868$664,242$375,302
Interest expense$475$2,337$9,132-$59,540$32,127$29,529$50,126$16,797
Pretax income-$3.00M$210,657-$626,773-$1.95M-$295,094$75,977-$531,155-$329,201
Income tax———$0$4,524$0$42,948—
Net income-$3.00M$211,965-$626,197-$1.95M-$291,004$83,389-$565,131-$317,478
EPS (basic)-0.150.03-0.08—-0.040.01-0.09—
EPS (diluted)-0.150.03-0.08—-0.040.01-0.09—
Weighted avg. shares (diluted)20.16M7.54M7.48M—6.48M6.48M6.42M—
Balance sheet
Cash & equivalents$10.87M$1.51M$1.46M$2.09M$2.90M$3.73M$4.18M$4.34M
Short-term investments$67,919$113,687$99,615$84,466——$101,125$13,272
Receivables$2,778——$3,324————
Inventory$1,065$1,514$1,085$1,057$1,113$6,369$2,585$1,574
Current assets$16.50M$2.97M$2.45M$2.97M$3.86M$9.18M$5.91M$5.47M
PP&E, net$14,897$14,655$16,933$19,153$21,844$31,876$32,133$33,588
Goodwill———$116,648$122,482$77,480—$0
Total assets$17.82M$4.51M$4.21M$4.57M$5.18M$10.60M$6.53M$6.41M
Current liabilities$5.01M$1.64M$1.53M$1.28M$2.25M$7.15M$2.66M$3.31M
Total liabilities$5.07M$1.71M$2.13M$1.88M$2.28M$7.20M$2.84M$3.53M
Shareholders' equity$12.69M$2.73M$2.01M$2.62M$2.84M$3.23M$3.59M$2.77M
Shares outstanding29.73M7.73M7.48M7.48M6.48M6.48M6.48M5.59M
Cash flow statement
Operating cash flow-$99,461$478,008-$192,539-$1.02M-$199,902$26,909-$555,333-$255,926
Capital expenditure$635-$2$766$87$18,006——$291
Free cash flow-$100,096$478,010-$193,305-$1.02M-$217,908——-$256,217
Investing cash flow$29,669-$100,953-$305,416-$173,405-$273,758-$441,523-$300,000$341
Financing cash flow$9.47M-$340,540-$148,432-$268,593$624,450-$77,372$656,229$3.65M
Depreciation & amortization$2,255$2,047$2,091-$3,387$16,219$3,380$3,282$2,643
Share buybacks———————$1

Free plan shows the latest 8 periods; Pro shows all 23 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.